Diagnostic Virology & Molecular Analysis

Diagnostics market is still incipient and is predicted to reach $3.5 billion by 2020 from the radical value of $1.1 billion, growing at a CAGR of about 20% during the predicted period of 2014 to 2020. The Global Diagnostic Market is categorized based on indication, geography and technology.  The crucial drivers for this market are the discovery and increase in utilization and study of biomarkers and co-development of drugs and various therapies corresponding to these diagnostics. Nevertheless, the costs pertinent with drug development could contravene the growth of diagnostic market. Scope for this market prevails in progressing diagnostics for various infectious and hereditary conditions.

Diagnostic virology is now a crux in pathology and in medical practice. Various approaches are being optimized for the laboratory diagnosis of viral infections, antigen and nucleic acid detection, and serology. The technique of viral culturing is dwindling as novel immunological and molecular tests detect and provide accurate and more rapid results. In the last decade, both qualitative and the quantitative nucleic acid detection techniques has had an extensive impact on viral diagnostics. With advances in self-regulating nucleic-acid sample isolation methods, and real-time detection techniques; a new inception of assays for clinically important viruses is being developed. These technological enhancements potentially generate results within a short time interval. Moreover, the capability of these state-of-the-art technologies characterizes viruses efficiently by the process of sequencing thereby opening new probabilities for further epidemiological studies. 

  • Nucleic acid detection in Viral infections
  • Molecular techniques
  • Quality and infection control
  • Antiviral agents

Related Conference of Diagnostic Virology & Molecular Analysis

Diagnostic Virology & Molecular Analysis Conference Speakers